Objectives: Mesothelin (MSLN) is overexpressed in pancreatic ductal adenocarcinoma (PDAC), promoting cell proliferation, migration, and inhibiting apoptosis. The gene discussed is MSLN; the disease is pancreatic ductal adenocarcinoma.